miR-194-5p targets SOCS2 to predict pegIFNα treatment response in HBeAg-positive chronic hepatitis B patients
miR-194-5p may predict pegIFNα response in HBeAg-positive CHB. It regulates interferon signaling by targeting SOCS2 and modulating the JAK-STAT pathway activation, suggesting the miR-194-5p/SOCS2 axis as a potential therapeutic target.
Authors
- Y Z Chen
- LijuanZhang
- Lihua Ling
Institutions
- Soochow University (CN)
- The First Hospital of Kunming (CN)
- Sanming University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Virology Journal
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1186/s12985-026-03090-9
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00